THE USE OF SMALL MOLECULE CYSTEINE PROTEASE INHIBITORS, E64D/E64C, FOR TRAUMATIC BRAIN INJURY DRUG DEVELOPMENT

被引：0
|
作者：
Hook, Greg [1 ]
Jacobsen, Steven [2 ]
Grabstein, Kenneth [3 ]
Kindy, Mark [4 ]
Hook, Vivian [5 ]
机构：
[1] Amer Life Sci Pharmaceut, La Jolla, CA USA
[2] AstraZeneca Neurosci IMed, Cambridge, MA USA
[3] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA
[4] Univ S Florida, Dept Pharmaceut Sci, Tampa, FL USA
[5] Univ Calif San Diego, Dept Neurosci, Skaggs Sch Pharm, La Jolla, CA 92093 USA
来源：
JOURNAL OF NEUROTRAUMA | 2016年 / 33卷 / 13期
关键词：
cysteine proteases; E64d; E64c;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
PSA-166
引用
收藏
页码：A71 / A72
页数：2
相关论文
共 29 条
  • [1] Cathepsin B is a New Drug Target for Traumatic Brain injury Therapeutics: evidence for E64d as a Promising Lead Drug Candidate
    Hook, Gregory
    Jacobsen, J. Steven
    Grabstein, Kenneth
    Kindy, Mark
    Hook, Vivian
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [2] ESTER AND AMIDE DERIVATIVES OF E64C AS INHIBITORS OF PLATELET CALPAINS
    HUANG, ZY
    MCGOWAN, EB
    DETWILER, TC
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (11) : 2048 - 2054
  • [3] Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d
    Eksi, S.
    Czesny, B.
    van Gemert, G. -J.
    Sauerwein, R. W.
    Eling, W.
    Williamson, K. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) : 1064 - 1070
  • [4] THE EFFECT OF PROTEASE INHIBITORS, LEUPEPTIN AND E64D, ON DIFFERENTIATION OF C2C12 MYOBLASTS IN TISSUE-CULTURE
    KUMAR, A
    SHAFIQ, S
    WADGAONKAR, R
    STRACHER, A
    CELLULAR AND MOLECULAR BIOLOGY, 1992, 38 (05) : 477 - 483
  • [5] E64d, a membrane-permeable cysteine protease inhibitor, attenuates the effects of parathyroid hormone on osteoblasts in vitro
    Murray, EJB
    Grisanti, MS
    Bentley, GV
    Murray, SS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (09): : 1090 - 1094
  • [6] IMPACT OF CYSTEINE PROTEASE INHIBITOR, E-64D, PROTEASE ACTIVITY AND PROTEIN BIOMARKER LEVELS AFTER BRAIN INJURY
    Thangavelu, Bharani
    Gilsdorf, Janice
    Shear, Deborah A.
    Boutte, Angela M.
    JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : A83 - A83
  • [7] Research finds cysteine protease inhibitor, E64d, may have potential for treating Alzheimer's disease patients
    不详
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (07) : 922 - 922
  • [8] Electrostatic complementarity in pseudoreceptor modeling based on drug molecule crystal structures: the case of loxistatin acid (E64c)
    Shi, Ming W.
    Sobolev, Alexandre N.
    Schirmeister, Tanja
    Engels, Bernd
    Schmidt, Thomas C.
    Luger, Peter
    Mebs, Stefan
    Dittrich, Birger
    Chen, Yu-Sheng
    Bak, Joanna M.
    Jayatilaka, Dylan
    Bond, Charles S.
    Turner, Michael J.
    Stewart, Scott G.
    Spackman, Mark A.
    Grabowsky, Simon
    NEW JOURNAL OF CHEMISTRY, 2015, 39 (03) : 1628 - 1633
  • [9] Brain Pyroglutamate Amyloid-β is Produced by Cathepsin B and is Reduced by the Cysteine Protease Inhibitor E64d, Representing a Potential Alzheimer's Disease Therapeutic
    Hook, Gregory
    Yu, Jin
    Toneff, Thomas
    Kindy, Mark
    Hook, Vivian
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (01) : 129 - 149
  • [10] CORONAVIRUS PROTEIN PROCESSING AND RNA-SYNTHESIS IS INHIBITED BY THE CYSTEINE PROTEINASE-INHIBITOR E64D
    KIM, JC
    SPENCE, RA
    CURRIER, PF
    LU, XT
    DENISON, MR
    VIROLOGY, 1995, 208 (01) : 1 - 8
123